baber/WOPTO huggingface dataset:
Patent NZ-573672-A (NZ)
Title: Improvements in receivers for television signals
Inventor: WILLAME XAVIER
IPC: H04N21/458
Filed: 2002-11-13
Abstract: A method of controlling a recorder to record programmes is disclosed. The method comprises: storing a priority list identifying types of programmes to be recorded and their relative priorities; storing timing information relating to one or more programmes to be recorded together with information identifying the type of programme to be recorded; receiving a data stream including data representing programme content, programme identity data and data identifying the broadcast times of programmes; comparing the stored timing information with the received data identifying the broadcast times of programmes; adjusting the stored timing information in the event of a change as determined from the received data identifying the broadcast times of programmes; comparing entries on the priority list with the stored timing and type information for each programme to be recorded; and revising the stored timing information in the event of a conflict between timing information for two or more programmes to be recorded, depending on the relative priorities of the conflicting programmes.
Patent NZ-581284-A (NZ)
Title: Media distribution over a network utilising unicast, multicast and peer-to-peer distribution
Inventor: KOLHI JOHAN
IPC: H04L12/18
Filed: 2007-05-31
Abstract: A network node and a method of operating the network node to distribute media across an IP network is disclosed. The network node includes multicast and peer-to-peer ingress interfaces, and unicast and peer-to-peer egress interfaces. The node also includes a first selector for selecting a multicast or peer-to-peer ingress interface then receiving media packets at the selected interface; a packet handler for determining from packet information whether the packet can be cached and, if permitted, caching the packet; and a second selector for selecting a unicast or peer-to-peer egress interface then forwarding packets to at least one further node over that interface such that the media packets received at an ingress interface that uses one media distribution mechanism may be forwarded over an egress interface that uses a different media distribution mechanism.
Patent NZ-588810-A (NZ)
Title: Medication delivery device including dose setting mechanism
Inventor: HARMS MICHAEL
IPC: A61M5/24
Filed: 2009-04-17
Abstract: A medication delivery device (1) comprising: a medication receptacle (6), a dosing mechanism comprising: a piston rod (17) a drive device (19), a dose setting member (27) and a dose limiting member (28) which prevents the setting of a dose of medication which exceeds an amount of medication contained in the medication receptacle and a housing (3). The dose limiting member is designed for axial movement in a proximal direction with respect to the piston rod during dose setting and comprises a first stop element (35) and the piston rod comprises a second stop element (36). The first and second stop elements stop an axial movement of the dose limiting member in the proximal direction with respect to the piston rod when the first and second stop elements catch, thereby limiting a movement of the dose setting member for increasing a set dose of medication to be delivered. The dose limiting member and the piston rod only interact directly, when the first and second stop elements catch.
Patent NZ-596671-A (NZ)
Title: Assays for influenza virus hemagglutinins
Inventor: DORMITZER PHILIP
IPC: A61K38/16
Filed: 2010-05-28
Abstract: 596671 ASSAYS FOR INFLUENZA VIRUS HEMAGGLUTININS Provided is a method for purifying influenza virus HA in a sample, comprising steps of: (i) ultrafiltration of the sample using a membrane which retains any denatured or aggregated HA to provide a filtrate; and (ii) RP-HPLC of the filtrate to separate any HA therein from any other components therein. Further provided are specific membrane cut-offs and RP-HPLC support materials for the method.
Patent NZ-598499-A (NZ)
Title: Pump with float fixed to piston moving vertically in cylinder and pumping due to up and down tidal motion
Inventor: SMITH ALVIN
IPC: F03B13/18
Filed: 2010-09-08
Abstract: A wave-powered pumping device for location in a body of water is described. The pumping device includes a submersible cylinder to be anchored to the bed of the body of water, the cylinder defining a bore. An underwater float acts on the cylinder and is arranged to urge the cylinder into an upright orientation in the water. A surface float is arranged to float at, or close enough to, the surface of the body of water in use to move up and down in the body of water in accordance with wave movement and tidal movement. An elongate member depends from the surface float. The elongate member extends telescopically into the bore of the submersible cylinder to define a pumping chamber within the cylinder. The volume of the pumping chamber varies with wave movement in a pumping cycle to draw fluid into the pumping chamber on an upstroke of the elongate member and to pump fluid out of the pumping chamber on a downstroke of the elongate member. The length of the pumping chamber varies with tidal movement to adjust to changing tidal depth by extending or retracting the elongate member relative to the cylinder while effective pumping cycles continue across a tidal range without needing to move the cylinder with respect to the bed of the body of water. To the extent that the elongate member is retracted into the bore of the cylinder, the elongate member occupies a majority of the cross-sectional area of the bore.
Patent NZ-600534-A (NZ)
Title: Systems and methods for a reed valve module and valve assembly
Inventor: MOHAMED ZAHROOF
IPC: F16K15/16
Filed: 2010-11-18
Abstract: A reed valve module (46) suitable for a compressor comprises a body (610) and a single or plurality of reed petals (620). The body (610) includes a seating surface (640); one or more sealing faces and one or more fluid conduits (650) leading from the seating surface (640) to the sealing faces. The single or plurality of reed petals (620) is positioned over the sealing face of the module body (610). The cavity of the valve body (610) is reinforced by ribs (660, 670), the end surfaces of which are flush with the sealing face and spaced to enable the reed petals (620) to withstand the differential pressure acting on them.
Patent NZ-603753-A (NZ)
Title: A magnetic screen
Inventor: BAKER WILLIAM JOHN
IPC: B03C1/02
Filed: 2011-05-02
Abstract: Disclosed is a magnetic screen assembly (13) for the magnetic separation of ferrous and magnetic materials from a stream passing through the device. The assembly (13) is to be located in a duct (10) to screen a flowable substance passing in a direction (11). The assembly (13) has a screening position so that the substance passes through the screen, and a cleaning position at which the screen assembly (13) is spaced outwardly relative to the housing (12) to facilitate cleaning of the assembly (13). The screen includes a base; a plurality of magnetic bars mounted on the base so as to be supported thereby, the bars being generally parallel and transversely spaced so as to provide an aperture between each adjacent pair of bars, each aperture having a width that extends between the adjacent pair of bars. The bars are arranged in a first set and a second set, with at least two of the bars, of at least one of the sets, each being independently moveable relative to the base in a direction generally transverse of the bars to adjust the aperture size by altering said width.
Patent NZ-614844-A (NZ)
Title: Improved composite system for packaging
Inventor: KAISIG CARSTEN
IPC: B32B27/10
Filed: 2012-03-08
Abstract: A multi-layer laminate for producing food packaging comprises a paper layer and a barrier layer. The laminate does not comprise any metal foil. The barrier layer comprises a biodegradable material, and comprises a carrier layer and a vapour-deposited barrier material layer. The carrier layer consists of polylactic acid materials or cellophane, and the barrier material layer consists of vapour-deposited (semi)metal oxides.
Patent NZ-615671-A (NZ)
Title: An apparatus for mounting an anatomical positioner on a patient care platform
Inventor: CAMPAGNA MICHAEL
IPC: A61B6/04
Filed: 2009-06-30
Abstract: Disclosed is an apparatus for mounting an anatomical positioner on a patient care platform in the form of a table mount for use with a Citow Cervical Visualizer type shoulder press to allow the correct positioning of a patient without the assistance of an operator when undergoing x-ray or radiation therapy. The anatomical positioner includes a clamping mechanism for allowing an operator to quickly and securely join the apparatus to the patient care platform. Guide rails are joined to the clamping mechanism. The guide rails extend away from the patient care platform. Slides slidably join to the guide rails to allow the operator to position the anatomical positioner to impart a force on a patient on the patient care platform. The slides include brakes for at least stopping movement in a direction away from the patient care platform, and brake releases for releasing the brakes. Supports join to the slides for supporting the anatomical positioner. The supports have restraints for allowing the operator to quickly secure and adjust the anatomical positioner, whereby the anatomical positioner is positioned by the operator to impart the force on the patient and locked in place.
Patent NZ-627915-A (NZ)
Title: Probiotic derived non-viable material for infection prevention and treatment
Inventor: VAN TOL ERIC A F
IPC: C12R1/225
Filed: 2013-03-18
Abstract: Disclosed is the use of a composition comprising a culture supernatant from a late exponential growth phase of a probiotic batch-cultivation process, in the manufacture of composition for the treatment or prevention of infection by a pathogen, wherein the composition is obtained by a process comprising the steps of (a) subjecting a probiotic to cultivation in a suitable culture medium using a batch process; (b) harvesting the culture supernatant at a late exponential growth phase of the cultivation step, which phase is defined with reference to the second half of the time between the lag phase and the stationary phase of the batch-cultivation process; (c) optionally removing low molecular weight constituents from the supernatant so as to retain molecular weight constituents above 5 kDa; (d) removing liquid contents from the culture supernatant so as to obtain the composition, and wherein the probiotic is Lactobacillus rhamnosus Goldin Gorbach (LGG).
Patent NZ-629456-A (NZ)
Title: Methods for treating cancer using tor kinase inhibitor combination therapy
Inventor: CHOPRA RAJESH
IPC: A61P35/02
Filed: 2014-04-16
Abstract: Disclosed herein is the use of an effective amount of an effective amount of a TOR kinase inhibitor represented by structural formula (I) and an effective amount of IMiD immunomodulatory drug in the manufacture of a medicament for treating or preventing cancer, particularly blood borne cancer which includes a lymphoma, a leukemia or a mutliple myeloma, wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-631595-A (NZ)
Title: Systems and methods for detection of particles in a beneficial agent
Inventor: MATAYOSHI EDMUND
IPC: G01N21/90
Filed: 2013-05-23
Abstract: Disclosed are a method and a system for inspecting a liquid beneficial agent contained within a container (206). The method includes selectively illuminates at least a portion of the liquid beneficial agent; obtains an image from the illuminated portion of the liquid beneficial agent; analysing image data representing the image. A data processor (501) is used for obtaining a particle concentration; measuring an image intensity value of the image data using the data processor (501); and determining a quality level of the liquid beneficial agent using the data processor (501) based on the particle concentration and the measured image intensity value. The liquid beneficial agent is rejected if the quality level is below a predetermined threshold. The liquid beneficial agent can be biologies, small molecule pharmaceuticals, nutritional products, or combinations thereof. The container may be a syringe (206).
Patent NZ-700609-A (NZ)
Title: Enzyme-altered metabolite activity
Inventor: KOEPKE MICHAEL
IPC: C12P7/04
Filed: 2013-04-04
Abstract: The present invention relates to mutant alcohol dehydrogenase enzymes, microorganisms comprising same, and methods for the production of one or more products by microbial fermentation. More specifically, the present invention relates to a Clostridium autoethanogenum alcohol dehydrogenase comprising at least one amino acid substitution selected from the group consisting of: Gly198Asp, Gly198Ile, Gly198Leu, Gly198Val, Ser199Asp, Ser199Glu, Ser199Leu, Ser199Val, Arg200Glu, Pro201Asp, Pro201Glu, Tyr218Ala, Tyr218Phe, Tyr218Gly, Tyr218Ser and Tyr218Val; wherein the mutant alcohol dehydrogenase has increased specificity for at least one first substrate over at least one second substrate, wherein: the first substrate is acetone and the second substrate is MEK; the first substrate is acetone and the second substrate is acetaldehyde; the first substrate is acetone and the second substrate is acetoin; the first substrate is MEK and the second substrate is acetaldehyde; the first substrate is MEK and the second substrate is acetoin; the first substrate is acetoin and the second substrate is acetone; the first substrate is acetoin and the second substrate is MEK; the first substrate is acetoin and the second substrate is acetaldehyde; the first substrate is acetaldehyde and the second substrate is acetone; the first substrate is acetaldehyde and the second substrate is acetoin; or, the first substrate is acetaldehyde and the second substrate is MEK. The invention also provides recombinant microorganisms comprising a nucleic acid encoding said Clostridium autoethanogenum alcohol dehydrogenase, methods of making said recombinant microorganisms and methods for the production of one or more of isopropanol, ethanol, 2,3-butanediol, 2-butanol, acetoin, MEK, acetaldehyde, and acetone using said recombinant microorganisms.
Patent NZ-704605-A (NZ)
Title: Method and apparatus for measuring reaction forces
Inventor: RONCHI ANDREW JAMES
IPC: G01P15/08
Filed: 2013-07-24
Abstract: Apparatus is disclosed for monitoring, measuring and/or estimating a force applied to a body or body part of a vertebral mammal. The apparatus includes an acceleration sensor for measuring acceleration of the body or body part relative to an inertial frame of reference and for providing data indicative of the acceleration. The acceleration sensor includes at least one inertial sensor, a memory device adapted for storing the data, and a processor adapted for processing the data to evaluate a reaction force that correlates to the data. The processor may be configured to execute an algorithm for evaluating the reaction force, based on one or more correlation components such as mass, speed and/or velocity associated with the body or body part. A method of monitoring and/or estimating a force applied to a body or body part of a vertebral mammal is also disclosed.
Patent NZ-710765-A (NZ)
Title: 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
Inventor: AMANS DOMINIQUE
IPC: C07D413/04
Filed: 2014-03-12
Abstract: The present invention relates to novel compounds of formula (I), wherein R1 is C1-4alkyl; R2 is C1-4alkyl, C3-7cycloalkyl, -CH2CF3, -CH2OCH3 or heterocyclyl; R3 is C1-4alkyl, -CH2F, -CH2OH or -CH2O(O)CH3; R4 when present is as defined in claim 1; R5 when present is H, halo, hydroxy or C1-6alkoxy; A is -NH-, -O-, -S-, -SO-, -SO2-, -N(C1-4alkyl)- or -NC(O)(CH3)-; V is phenyl, heteroaromatic or pyridone any of which may be optionally substituted by 1, 2 or 3 substituents; W is CH or N; X is C or N; Y is C or N; and Z is CH or N; subject to the proviso that no more than 2 of W, X, Y and Z are N, pharmaceutical compositions containing such compounds and to their use as bromodomain inhibitors.
Patent NZ-714235-A (NZ)
Title: Pant-type disposable diaper and manufacturing method therefor
Inventor: SUGIYAMA KATSUHIKO
IPC: A61F13/496
Filed: 2014-01-15
Abstract: [Problem] To provide a pant-type disposable diaper for which the side seal sections formed on the left and right sides of the diaper are attractive and the side seal sections have a good feel. [Solution] A pant-type disposable diaper in which a pair of side seal sections (4) is formed, wherein the pair of side seal sections (4) comprise main seam areas (40) that extend in the vertical direction and secondary seam areas (50) that are positioned to the outside of the main seam areas (40) in the left-right direction and extend in the vertical direction. The secondary seam areas (50) here are areas formed by providing one or multiple embossed rows in which multiple secondary embossed parts (51) form a line at intervals in the vertical direction. The seam strength of the secondary seam areas (50) is set to be weaker than the seam strength of the main seam areas (40).
Patent NZ-716084-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C12P7/00
Filed: 2010-01-08
Abstract: Discloses a method of processing lignocellulosic biomass to a carboxylic acid or a salt of the carboxylic acid, the method comprising: treating the lignocellulosic biomass to reduce its recalcitrance, thereby producing treated biomass; saccharifying a first portion of the treated biomass with an enzyme and/or with acid, thereby producing saccharified material; fermenting the saccharified material in a fermentation vessel by utilising a microorganism or a mixture of microorganisms to produce the carboxylic acid or the salt of the carboxylic acid; thermochemically converting a second portion of the treated biomass to produce syngas; and feeding the syngas into the fermentation vessel during fermenting.
Patent NZ-719939-A (NZ)
Title: Compounds for positron emission tomography
Inventor: VLAHOV IONTCHO R
IPC: A61K51/04
Filed: 2014-11-13
Abstract: Described herein are compounds, compositions, and methods for diagnosing and/or monitoring pathogenic disease using positron emission tomography. Also described are conjugates of the formula B-L-P, wherein B is a radical of a targeting agent selected from vitamin receptor binding ligands (such as folate), PSMA binding ligands, or PSMA inhibitors; L is a divalent linker comprising aspartic acid, lysine, or arginine, and P is a radical of an imaging agent or radiotherapy agent, such as a radionuclide or radionuclide containing group, or a radical of a compound capable of binding a radionuclide, such as a metal chelating group.
Patent NZ-719953-A (NZ)
Title: Methods of treatment of ocular conditions with a sustained drug delivery implant
Inventor: SHIAH JANE-GUO
IPC: A61K9/00
Filed: 2014-11-14
Abstract: Intraocular implants may include a corticosteroid and a biodegradable polymer associated with the corticosteroid to facilitate the release of the corticosteroid into an eye for a period of time. In some embodiments, ocular conditions, such as diabetic macular edema can be treated through administration of an intraocular implant including a corticosteroid and a biodegradable polymer associated with the corticosteroid to the eye of a human at a frequency of about once every six months to about once a year.
Patent NZ-748858-A (NZ)
Title: Compositions and methods for inhibiting expression of transthyretin
Inventor: SAH DINAH WEN-YEE
IPC: C07H21/02
Filed: 2009-10-20
Abstract: Discloses a double-stranded ribonucleic acid (dsRNA) for inhibiting expression of transthyretin (TTR), wherein the dsRNA comprises a sense strand and an antisense strand and the antisense and sense strands comprise the nucleotide sequences of: AAuACcACCUCUGcAUGCUdTdT and AGcAuGcAGAGGuGGuAuudTdT, UGAAuACcACCUCUGcAUGdTdT and cAuGcAGAGGuGGuAuucAdTdT, or GUGAAuACcACCUCUGcAUdTdT and AuGcAGAGGuGGuAuucAcdTdT.
Patent NZ-751653-A (NZ)
Title: A control unit for a beer production system
Inventor: TOOMBS PETER
IPC: G05B1/00
Filed: 2012-03-28
Abstract: Disclosed is a control unit for a beer production system (400). A beer production module (414) receives a selection of one of a plurality of recipes for beer stored on a memory (408) and controls formation of a mixture of ingredients, including at least wort concentrate, in accordance with the selected recipe. The module (414) also monitors and controls conditions associated with production of beer from the mixture of ingredients including at least temperature, and carbon dioxide evolution.
Patent NZ-759918-A (NZ)
Title: Image contrast enhancement for optical microscopy
Inventor: BALAUR EUGENIU
IPC: G02B27/56
Filed: 2018-05-22
Abstract: A method of imaging an object including: supporting the object on a plasmonic layer of a sample holder, wherein the plasmonic layer defines a periodic array of sub-micron structures adjacent the object; exposing the sample holder to light such that: a first portion of the light is transmitted through either: (i) the plasmonic layer but not the object, or (ii) the plasmonic layer and a first section of the object; and a second portion of the light is transmitted through the plasmonic layer and at least a second section of the object; wherein the light interacts with at least the plasmonic layer such that: the first portion of the transmitted light is characterised by one or more first surface plasmon resonance peaks, and the second portion of the transmitted light is characterised by one or more second surface plasmon resonance peaks that are wavelength shifted from the first surface plasmon resonance peaks as a result of the object affecting plasmons propagating within the plasmonic layer; and constructing an image of the object from the first and the second portions of the transmitted light to thereby enable the object to be spatially resolved.
Patent NZ-762865-A (NZ)
Title: Psma-targeting amanitin conjugates
Inventor: GALLO FRANCESCA
IPC: A61P35/00
Filed: 2018-09-24
Abstract: The invention relates to a PSMA-targeting conjugate comprising (a) an amatoxin such as amanitin; (b) a small molecule PSMA-targeting moiety; and (c) optionally a linker linking said amatoxin and said small molecule PSMA-targeting moiety. The specification shows that amatoxins can be conjugated with a PSMA-targeting moiety based on 2-[3-(1,3-dicarboxy-propyl)ureido]pentanedioic acid (I) or 6-amino-2-[3-(1,3-dicarboxypropyl)ureido]-hexanoic acid (II) to produce conjugates with good selectivity and targeting index values. In some embodiments, said conjugates are attached to a half-life extension moiety. The conjugates in the specification also have improved half-lives. The invention furthermore relates to a pharmaceutical composition comprising such conjugates.
Patent PT-102839-A (PT)
Title: Pharmaceutical composition for treating rheumatoid arthritis, comprises oil of laurel obtained by mechanical expression of Laurus novocanariensis
Inventor: COSTA MARIA DO CEU GONCALVES D
IPC: A61P29/00
Filed: 2002-09-20
Abstract: An anti-inflammatory pharmaceutical composition incorporates oil of laurel obtained by mechanical expression of Laurus novocanariensis. The medicine prepared is intended for the treatment of rheumatoid arthritis in mammals, including human beings.
Patent PT-103072-A (PT)
Inventor: LOPES JOSE CARLOS BRITO
IPC: B01J19/00
Filed: 2004-02-13
Abstract: A static continuous flow mixer, with or without reaction, is provided with basic cells, which are individually provided with an individualized chamber (1). The basic cells are also provided with at least two connecting channels (2), at least two of them being oblique relatively to the resulting direction (x) of the flow in the mixer, and with at least two additional apertures (0) for connection with the exterior. The cells interconnect successively in the space, forming a network. The mixer promotes convective processes. The dimensions (Dj, li, di, phi), the geometry of the chambers (spherical or cylindrical) and of the channels (cylindrical or prismatic) may vary, as well as their quantity.